GlassScriptPhysician profile
Sharon C Kiang
NPI 1952572737
$46,367.22
in general payments reported to CMS, 2019-2025
14 companies · $10K in 2025
The $10K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,978 · 2020: $211 · 2021: $1,257 · 2022: $3,548 · 2023: $14K · 2024: $15K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Travel and Lodging: $6,563 · Food and Beverage: $3,257 · Grant: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,386.50 |
| Travel and Lodging | $6,563.18 |
| Food and Beverage | $3,256.71 |
| Grant | $166.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $32,471.23 | 2019-2025 | Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Bolton Medical INC | $5,919.20 | 2021-2024 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Endologix LLC | $3,989.92 | 2019-2024 | Alto Abdominal Stent Graft System |
| Shockwave Medical, INC | $1,567.83 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $1,163.87 | 2020-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Abbott Laboratories | $582.64 | 2019-2022 | |
| Boston Scientific Corporation | $166.50 | 2023 | |
| Cook Medical LLC | $156.96 | 2019-2024 | Hemospray, Cook |
| Aidoc Medical LTD | $120.00 | 2023 | Briefcase |
| Bard Peripheral Vascular, INC. | $87.09 | 2019 | |
| Lemaitre Vascular, INC. | $72.09 | 2019-2025 | Xenosure Biologic Patch |
| Medtronic, INC. | $27.89 | 2025 | Endurant Iis |
| Osiris Therapeutics INC. | $21.82 | 2019 | |
| Medtronic Vascular, INC. | $20.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Kiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.